お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:デジタルパソロジーの世界市場 (~2025年):製品 (AI・スキャナー・ソフトウェア・ストレージ)・タイプ (ヒト・動物)・用途 (遠隔診療・診断・創薬)・エンドユーザー・地域別
市場調査レポート
商品コード
967907

デジタルパソロジーの世界市場 (~2025年):製品 (AI・スキャナー・ソフトウェア・ストレージ)・タイプ (ヒト・動物)・用途 (遠隔診療・診断・創薬)・エンドユーザー・地域別

Digital Pathology Market by Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End-User - Global Forecast to 2025

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 211 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.66円
デジタルパソロジーの世界市場 (~2025年):製品 (AI・スキャナー・ソフトウェア・ストレージ)・タイプ (ヒト・動物)・用途 (遠隔診療・診断・創薬)・エンドユーザー・地域別
出版日: 2020年10月27日
発行: MarketsandMarkets
ページ情報: 英文 211 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界のデジタルパソロジーの市場規模は予測期間中13.8%のCAGRで推移し、2020年の5億5300万米ドルから、2025年には10億5400万米ドルの規模に成長すると予測されています。ラボ効率改善のためのデジタルパソロジーの導入拡大、癌の有病率の上昇、医薬品開発およびコンパニオン診断におけるデジタルパソロジー利用の増加、各種イニシアチブの増加などの要因が同市場の成長を推進しています。一方で、システムの高コスト性が市場のさらなる成長の妨げとなる見通しです。

製品別で見ると、スキャナー部門が2019年に最大のシェアを占め、予測期間中はソフトウェア部門が最大の成長を示すと予測されています。ソフトウェア部門の成長は、病理診断に向けたユーザーフレンドリーでアナリティカルな先進機能のアベイラビリティに起因する見通しです。また、地域別では、北米が期間中最大の成長率を示す見通しです。

当レポートでは、世界のデジタルパソロジーの市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、関連法規制、技術・特許の動向、市場規模の推移・予測、製品・タイプ・用途・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • COVID-19:影響分析
  • エコシステム・マーケットマップ
  • 販売価格
  • 法規制環境
  • 技術分析
  • 特許分析

第6章 市場分析・予測:製品別

  • スキャナー
    • 明視野スキャナー
    • 蛍光スキャナー
    • その他
  • ソフトウェア
    • 情報管理ソフトウェア
    • 画像解析ソフトウェア
    • 視覚化ソフトウェア
  • 通信システム
  • ストレージシステム

第7章 市場分析・予測:タイプ別

  • ヒト
  • 動物

第8章 市場分析・予測:用途別

  • 創薬
  • 診断
  • 遠隔診察
  • トレーニング・教育

第9章 市場分析・予測:エンドユーザー別

  • 製薬・バイオテクノロジー企業
  • 病院・リファレンスラボ
  • 学術機関・研究機関

第10章 市場分析・予測:地域・主要国別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • スウェーデン
    • デンマーク
    • フランス
    • その他
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他
  • その他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第11章 競合情勢

  • 市場評価の枠組み
  • 市場シェア分析
  • 地理的評価
  • R&D費
  • 競合シナリオ

第12章 企業評価マトリックス・企業プロファイル

  • 企業の評価マトリックス:定義・調査手法
  • 企業の評価マトリックス
  • 競合リーダーシップマッピング:新興企業/中小企業
  • 企業プロファイル
    • LEICA BIOSYSTEMS
    • KONINKLIJKE PHILIPS
    • HAMAMATSU PHOTONICS
    • F. HOFFMANN-LA ROCHE LTD.
    • SECTRA AB
    • 3DHISTECH
    • APOLLO ENTERPRISE IMAGING CORP.
    • XIFIN, INC.
    • HURON DIGITAL PATHOLOGY
    • VISIOPHARM
    • CORISTA
    • INDICA LABS
    • OBJECTIVE PATHOLOGY SERVICES
    • OPTRASCAN, INC.
    • GLENCOE SOFTWARE, INC.
    • PAIGE
  • 他の有力企業
    • PATHAI
    • KONFOONG BIOTECH INTERNATIONAL CO., LTD.
    • INSPIRATA, INC.
    • MIKROSCAN TECHNOLOGIES, INC.
    • PROSCIA, INC.
    • KANTERON SYSTEMS

第13章 付録

目次
Product Code: HIT 2608

Title:
Digital Pathology Market
by Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End-User (Pharmaceutical Companies, Hospitals) - Global Forecast to 2025.

The global digital pathology market is projected to reach USD 1,054 million by 2025 from USD 553 million in 2020, at a CAGR of 13.8% during the forecast period. The key factors driving the growth of this market include the

increasing adoption of digital pathology to enhance lab efficiency, rising prevalence of cancer, growing application of digital pathology in drug development & companion diagnostics, and increasing initiatives by industry players. However, the high cost of digital pathology systems is expected to restrict market growth to a certain extent.

"Adoption of artificial intelligence is expected to increase during the forecast period."

The adoption of AI in healthcare has been rising in recent years due to its ability to optimize clinical processes, thereby solving a variety of problems in the healthcare industry. AI helps patients receive correct diagnosis in a timely manner, maximize hospital efficiency, and reduce the waiting time for patients, thereby enhancing overall healthcare. AI helps in collecting, storing, and normalizing data along with tracing its lineage.

"The software segment will grow at the highest rate during the forecast period."

On the basis of product, the digital pathology market is segmented into scanners, software, communication systems, and storage systems. The scanners segment accounted for the largest share of the digital pathology market in 2019. The large share of this segment is mainly due to the increasing adoption of digital pathology solutions across the globe, and the high cost of scanners. On the other hand, the software segment is projected to witness the highest growth rate during the forecast period, due to the availability of user-friendly, analytical, and advanced functions for pathology diagnosis.

"By type, the human pathology segment accounted for the largest share of the digital pathology market in 2019."

On the basis of type, the global digital pathology market is segmented into human and veterinary pathology. The human pathology segment accounted for the largest share of the digital pathology market in 2019. The increasing number of cancer research activities and growing collaborations between academic research institutes, universities, and pathology laboratories are driving the increased uptake of digital systems in human pathology.

"The market in North America is projected to witness the highest growth rate during the forecast period (2020-2025)."

North America is projected to register the highest growth during the forecast period. This large share can be attributed to factors such as the rising prevalence of cancer and increasing initiatives by industry players. On the other hand, the Asia Pacific region is expected to grow at the second-highest CAGR during the forecast period. Factors such as a large patient population, shortage of pathologists, increasing initiatives in the healthcare industry by key market players, and rising adoption of advanced technologies for disease diagnosis are driving the growth of the digital pathology market in this region.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type (Supply-side): Tier 1: 29%, Tier 2: 37%, and Tier 3: 34%
  • By Category (Demand-side): Pharmaceutical & Biotechnology Companies: 55%, Hospitals and Reference Laboratories: 35%, and Academic & Research Institutes: 10%
  • By Designation: C-level: 35%, Director-level: 25%, and Managers: 40%
  • By Region: North America: 35%, Europe: 32%, Asia: 22%, and the RoW: 11%

Leica Biosystems (US), Koninklijke Philips N.V. (Netherlands), and Hamamatsu Photonics K.K. (Japan) are the leading players in the global digital pathology market. Other notable players in this market include Roche (Switzerland), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), XIFIN (US), Huron Digital Pathology (Canada), Visiopharm A/S (Denmark), Corista (US), Indica Labs (US), Objective Pathology Services (Canada), Sectra AB (Sweden), OptraSCAN (India), Glencoe Software (US), KONFOONG BIOTECH INTERNATIONAL CO., LTD (China), Inspirata Inc. (US), Mikroscan Technologies (US), Proscia Inc. (US), and Kanteron Systems (Spain).

Research Coverage:

The report analyzes the digital pathology market and aims at estimating the market size and future growth potential of this market based on various segments such as product, type, application, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.

Reasons to Buy the Report:

The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the digital pathology market. The report analyzes the market based on the product, type, application, end user, and region.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the digital pathology market.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of digital pathology solutions across regions.
  • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the digital pathology market.
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the digital pathology market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Breakdown of primary sources
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY CATEGORY, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 5 ILLUSTRATIVE EXAMPLE OF LEICA BIOSYSTEMS (SUBSIDIARY OF DANAHER CORPORATION)
    • FIGURE 6 SUPPLY-SIDE ANALYSIS: DIGITAL PATHOLOGY MARKET (2019)
    • FIGURE 7 BOTTOM-UP APPROACH
    • FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE DIGITAL PATHOLOGY MARKET (2020-2025)
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 ASSUMPTIONS FOR THE STUDY
  • 2.6 COVID-19 HEALTH ASSESSMENT
  • 2.7 COVID-19 ECONOMIC ASSESSMENT
    • 2.7.1 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
  • 2.8 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO PERTAINING TO THE DIGITAL PATHOLOGY MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 13 DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
    • FIGURE 14 DIGITAL PATHOLOGY MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
    • FIGURE 15 DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
    • FIGURE 16 DIGITAL PATHOLOGY MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
    • FIGURE 17 GEOGRAPHICAL SNAPSHOT OF THE DIGITAL PATHOLOGY MARKET

4 PREMIUM INSIGHTS

  • 4.1 DIGITAL PATHOLOGY MARKET OVERVIEW
    • FIGURE 18 RISING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH
  • 4.2 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT AND COUNTRY (2019)
    • FIGURE 19 SCANNERS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN DIGITAL PATHOLOGY MARKET IN 2019
  • 4.3 DIGITAL PATHOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 20 UK AND CHINA TO WITNESS THE HIGHEST GROWTH IN THE DIGITAL PATHOLOGY MARKET DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • TABLE 1 MARKET DYNAMICS: IMPACT ANALYSIS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing adoption of digital pathology to enhance lab efficiency
      • 5.2.1.2 Rising prevalence of cancer
    • TABLE 2 GLOBAL CANCER INCIDENCE, 2018 VS. 2025
      • 5.2.1.3 Growing applications of digital pathology in drug development and companion diagnostics
      • 5.2.1.4 Increasing initiatives by industry players
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of digital pathology systems
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Introduction of affordable scanners for private pathology practices
      • 5.2.3.2 Increasing demand for personalized medicine
    • TABLE 3 GROWTH IN THE NUMBER OF PERSONALIZED MEDICINES, 2008-2016
      • 5.2.3.3 High growth opportunities in emerging economies
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Lack of trained pathologists
    • TABLE 4 NUMBER OF PATHOLOGISTS PER 100,000 POPULATION, BY COUNTRY, 2018
  • 5.3 COVID-19 IMPACT ANALYSIS
    • 5.3.1 IMPACT OF COVID-19 ON THE DIGITAL PATHOLOGY MARKET
    • FIGURE 21 IMPACT OF COVID-19 ON THE DIGITAL PATHOLOGY MARKET
  • 5.4 ECOSYSTEM MARKET MAP
    • FIGURE 22 DIGITAL PATHOLOGY MARKET: ECOSYSTEM MARKET MAP
  • 5.5 TRENDS IN AVERAGE SELLING PRICE
    • FIGURE 23 DIGITAL PATHOLOGY MARKET: AVERAGE REGIONAL PRICES OF DIGITAL PATHOLOGY SCANNERS
  • 5.6 IMPACT OF THE NEW IVD REGULATION ON DIFFERENT MARKETS
    • FIGURE 24 TIMELINE AND TRANSITION TO NEW MDR AND IVDR
    • 5.6.1 IMPACT ON CLINICAL LAB SERVICES
    • 5.6.2 IMPACT ON IVD
    • 5.6.3 IMPACT ON DIGITAL PATHOLOGY
  • 5.7 TECHNOLOGY ANALYSIS
    • 5.7.1 AI IN DIGITAL PATHOLOGY
    • TABLE 5 DIGITAL PATHOLOGY AI MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 5.8 PATENT ANALYSIS
    • 5.8.1 METHODOLOGY
    • 5.8.2 PUBLICATION TRENDS
    • FIGURE 25 PUBLICATION TRENDS, 2015-2020
    • 5.8.3 JURISDICTION ANALYSIS
    • FIGURE 26 JURISDICTION ANALYSIS, 2015-2020
    • 5.8.4 TOP APPLICANTS
    • FIGURE 27 TOP APPLICANTS, 2015-2020

6 DIGITAL PATHOLOGY MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 6 DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • 6.2 SCANNERS
    • 6.2.1 SCANNERS ACCOUNTED FOR THE LARGEST SHARE OF THE DIGITAL PATHOLOGY PRODUCTS MARKET IN 2019
    • TABLE 7 SCANNING MAGNIFICATION AND APPLICATIONS
    • TABLE 8 DIGITAL PATHOLOGY SCANNERS OFFERED BY KEY MARKET PLAYERS
    • TABLE 9 DIGITAL PATHOLOGY SCANNERS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 10 DIGITAL PATHOLOGY SCANNERS MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 11 DIGITAL PATHOLOGY SCANNERS MARKET, BY REGION, 2018-2025 (UNITS)
    • TABLE 12 DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 6.2.2 BRIGHTFIELD SCANNERS
    • TABLE 13 DIGITAL PATHOLOGY BRIGHTFIELD SCANNERS OFFERED BY KEY MARKET PLAYERS
    • TABLE 14 BRIGHTFIELD SCANNERS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • 6.2.3 FLUORESCENCE SCANNERS
    • TABLE 15 DIGITAL PATHOLOGY FLUORESCENCE SCANNERS OFFERED BY KEY MARKET PLAYERS
    • TABLE 16 FLUORESCENCE SCANNERS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • 6.2.4 OTHER DIGITAL PATHOLOGY SCANNERS
    • TABLE 17 OTHER DIGITAL PATHOLOGY SCANNERS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • 6.3 SOFTWARE
    • 6.3.1 DIGITAL PATHOLOGY SOFTWARE OFFERS ANALYTICAL AND HIGHLY ADVANCED FUNCTIONS NOT OFFERED BY TRADITIONAL MICROSCOPES
    • TABLE 18 DIGITAL PATHOLOGY SOFTWARE OFFERED BY KEY MARKET PLAYERS
    • TABLE 19 DIGITAL PATHOLOGY SOFTWARE MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 20 DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • 6.3.2 INFORMATION MANAGEMENT SOFTWARE
    • TABLE 21 INFORMATION MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • 6.3.3 IMAGE ANALYSIS SOFTWARE
    • TABLE 22 IMAGE ANALYSIS SOFTWARE MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • 6.3.4 VISUALIZATION SOFTWARE
    • TABLE 23 VISUALIZATION SOFTWARE MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • 6.4 COMMUNICATION SYSTEMS
    • 6.4.1 INTRODUCTION OF CLOUD-BASED COMMUNICATION SYSTEMS PROVIDES IMPETUS TO MARKET GROWTH
    • TABLE 24 COMMUNICATION SYSTEMS USED IN DIGITAL PATHOLOGY
    • TABLE 25 DIGITAL PATHOLOGY COMMUNICATION SYSTEMS OFFERED BY KEY MARKET PLAYERS
    • TABLE 26 DIGITAL PATHOLOGY COMMUNICATION SYSTEMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • 6.5 STORAGE SYSTEMS
    • 6.5.1 NEED FOR STORING HIGH-QUALITY IMAGES IN A SAFE AND RELIABLE FORM TO DRIVE MARKET GROWTH
    • TABLE 27 DIGITAL PATHOLOGY STORAGE SYSTEMS OFFERED BY KEY MARKET PLAYERS
    • TABLE 28 DIGITAL PATHOLOGY STORAGE SYSTEMS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)

7 DIGITAL PATHOLOGY MARKET, BY TYPE

  • 7.1 INTRODUCTION
    • TABLE 29 DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • 7.2 HUMAN PATHOLOGY
    • 7.2.1 HUMAN PATHOLOGY SEGMENT TO REGISTER THE HIGHEST GROWTH IN THE FORECAST PERIOD
    • TABLE 30 HUMAN DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • 7.3 VETERINARY PATHOLOGY
    • 7.3.1 VETERINARY DIGITAL PATHOLOGY CUTS THE TURNAROUND TIME FOR ANIMAL DISEASE DIAGNOSIS-A KEY FACTOR DRIVING MARKET GROWTH
    • TABLE 31 VETERINARY DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)

8 DIGITAL PATHOLOGY MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 32 DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • 8.2 DRUG DISCOVERY
    • 8.2.1 INCREASING R&D SPENDING WILL PROVIDE IMPETUS TO MARKET GROWTH
    • TABLE 33 APPLICATIONS OF DIGITAL PATHOLOGY IN DRUG DISCOVERY/RESEARCH
    • TABLE 34 DIGITAL PATHOLOGY MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2018-2025 (USD MILLION)
  • 8.3 DISEASE DIAGNOSIS
    • 8.3.1 DISEASE DIAGNOSIS SEGMENT TO REGISTER STEADY GROWTH DURING THE FORECAST PERIOD
    • TABLE 35 DIGITAL PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY COUNTRY, 2018-2025 (USD MILLION)
  • 8.4 TELECONSULTATION
    • 8.4.1 THE NEED FOR ACCURATE, EFFICIENT, AND QUICK DIAGNOSIS IS EXPECTED TO DRIVE THE TELECONSULTATION MARKET DURING THE FORECAST PERIOD
    • TABLE 36 DIGITAL PATHOLOGY MARKET FOR TELECONSULTATION, BY COUNTRY, 2018-2025 (USD MILLION)
  • 8.5 TRAINING & EDUCATION
    • 8.5.1 DIGITAL PATHOLOGY CAN IMPROVE EDUCATION AND TRAINING PROVIDED TO PATHOLOGISTS
    • TABLE 37 DIGITAL PATHOLOGY MARKET FOR TRAINING & EDUCATION, BY COUNTRY, 2018-2025 (USD MILLION)

9 DIGITAL PATHOLOGY MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 38 DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • TABLE 39 DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • TABLE 40 DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2018-2025 (UNITS)
  • 9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 9.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ARE THE LARGEST & FASTEST-GROWING END USERS OF THE DIGITAL PATHOLOGY MARKET
    • TABLE 41 DIGITAL PATHOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 42 DIGITAL PATHOLOGY SCANNERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 43 DIGITAL PATHOLOGY SCANNERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2025 (UNITS)
  • 9.3 HOSPITALS & REFERENCE LABORATORIES
    • 9.3.1 INCREASING ADOPTION OF DIGITAL PATHOLOGY SOLUTIONS IN HOSPITALS TO DRIVE THE GROWTH OF THIS END-USER SEGMENT
    • TABLE 44 HOSPITAL DEPLOYMENT OF DIGITAL PATHOLOGY SOLUTIONS
    • TABLE 45 DIGITAL PATHOLOGY MARKET FOR HOSPITALS & REFERENCE LABORATORIES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 46 DIGITAL PATHOLOGY SCANNERS MARKET FOR HOSPITALS & REFERENCE LABORATORIES, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 47 DIGITAL PATHOLOGY SCANNERS MARKET FOR HOSPITALS & REFERENCE LABORATORIES, BY REGION, 2018-2025 (UNITS)
  • 9.4 ACADEMIC & RESEARCH INSTITUTES
    • 9.4.1 ACADEMIC & RESEARCH INSTITUTES SEGMENT TO REGISTER STEADY GROWTH DURING THE FORECAST PERIOD
    • TABLE 48 DIGITAL PATHOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 49 DIGITAL PATHOLOGY SCANNERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 50 DIGITAL PATHOLOGY SCANNERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2025 (UNITS)

10 DIGITAL PATHOLOGY MARKET, BY REGION

  • 10.1 INTRODUCTION
    • FIGURE 28 DIGITAL PATHOLOGY MARKET, BY REGION, 2020 VS. 2025 (USD MILLION)
    • TABLE 51 DIGITAL PATHOLOGY MARKET, BY REGION, 2018-2025 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 29 NORTH AMERICA: DIGITAL PATHOLOGY MARKET SNAPSHOT
    • TABLE 52 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 53 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 54 NORTH AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 55 NORTH AMERICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 56 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 57 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 58 NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • TABLE 59 NORTH AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • TABLE 60 NORTH AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2018-2025 (UNITS)
    • 10.2.1 US
      • 10.2.1.1 Favorable reimbursement scenario for digital pathology in the US
    • TABLE 61 US: CANCER CASES, 2018
    • TABLE 62 CONFERENCES/MEETINGS/COURSES/WORKSHOPS HELD/TO BE HELD IN THE US
    • TABLE 63 US: KEY MACROINDICATORS
    • TABLE 64 US: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 65 US: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 66 US: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 67 US: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 68 US: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 69 US: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 Growing need for high-quality cancer diagnosis and government initiatives to drive the market growth in Canada
    • TABLE 70 CANADA: DIGITAL PATHOLOGY INITIATIVES AND FUNDING
    • TABLE 71 CANADA: KEY MACROINDICATORS
    • TABLE 72 CANADA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 73 CANADA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 74 CANADA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 75 CANADA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 76 CANADA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 77 CANADA: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025(USD MILLION)
  • 10.3 EUROPE
    • FIGURE 30 EUROPE: DIGITAL PATHOLOGY MARKET SNAPSHOT
    • TABLE 78 EUROPE: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 79 EUROPE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 80 EUROPE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 81 EUROPE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 82 EUROPE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 83 EUROPE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 84 EUROPE: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • TABLE 85 EUROPE: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • TABLE 86 EUROPE: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2018-2025 (UNITS)
    • 10.3.1 UK
      • 10.3.1.1 The UK is the largest market for digital pathology in Europe
    • TABLE 87 CONFERENCES/COURSES HELD/TO BE HELD IN THE UK
    • TABLE 88 UK: KEY MACROINDICATORS
    • TABLE 89 UK: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 90 UK: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 91 UK: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 92 UK: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 93 UK: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 94 UK: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.3.2 GERMANY
      • 10.3.2.1 High healthcare expenditure and supportive health insurance to drive market growth in Germany
    • TABLE 95 GERMANY: CANCER INCIDENCE, BY TYPE, 2018 VS. 2025
    • TABLE 96 GERMANY: KEY MACROINDICATORS
    • TABLE 97 GERMANY: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 98 GERMANY: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 99 GERMANY: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 100 GERMANY: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)S
    • TABLE 101 GERMANY: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 102 GERMANY: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.3.3 SWEDEN
      • 10.3.3.1 Increasing government initiatives and deployment of digital pathology solutions
    • TABLE 103 SWEDEN: CANCER CASES, 2018
    • TABLE 104 SWEDEN: KEY MACROINDICATORS
    • TABLE 105 SWEDEN: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025(USD MILLION)
    • TABLE 106 SWEDEN: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 107 SWEDEN: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 108 SWEDEN: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 109 SWEDEN: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 110 SWEDEN: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.3.4 DENMARK
      • 10.3.4.1 High cancer prevalence to drive the market growth in Denmark
    • FIGURE 31 DENMARK: CANCER PREVALENCE, 2012-2020
    • TABLE 111 DENMARK: KEY MACROINDICATORS
    • TABLE 112 DENMARK: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 113 DENMARK: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 114 DENMARK: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 115 DENMARK: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 116 DENMARK: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 117 DENMARK: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.3.5 FRANCE
      • 10.3.5.1 Increasing incidence of cancer to drive the market growth during the forecast period
    • TABLE 118 FRANCE: CANCER INCIDENCE, BY TYPE, 2018 VS. 2025
    • TABLE 119 FRANCE: KEY MACROINDICATORS
    • TABLE 120 FRANCE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 121 FRANCE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 122 FRANCE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 123 FRANCE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 124 FRANCE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 125 FRANCE: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.3.6 REST OF EUROPE (ROE)
    • TABLE 126 ROE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 127 ROE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 128 ROE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 129 ROE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 130 ROE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 131 ROE: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • TABLE 132 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
    • TABLE 133 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 134 ASIA PACIFIC: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 135 ASIA PACIFIC: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 136 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 137 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 138 ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • TABLE 139 ASIA PACIFIC: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • TABLE 140 ASIA PACIFIC: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2018-2025 (UNITS)
    • 10.4.1 CHINA
      • 10.4.1.1 Favorable initiatives for the adoption of telepathology in China
    • TABLE 141 CHINA: CANCER CASES, 2018
    • TABLE 142 CHINA: KEY MACROINDICATORS
    • TABLE 143 CHINA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 144 CHINA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 145 CHINA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 146 CHINA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 147 CHINA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 148 CHINA: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.4.2 JAPAN
      • 10.4.2.1 Increasing initiatives by industry players for cancer diagnosis to drive market growth
    • TABLE 149 JAPAN: KEY MACROINDICATORS
    • TABLE 150 JAPAN: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 151 JAPAN: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 152 JAPAN: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 153 JAPAN: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 154 JAPAN: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 155 JAPAN: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Growing number of cancer cases in India to drive the market growth
    • TABLE 156 INDIA: KEY MACROINDICATORS
    • TABLE 157 INDIA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 158 INDIA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 159 INDIA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 160 INDIA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 161 INDIA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 162 INDIA: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.4.4 REST OF ASIA PACIFIC (ROAPAC)
    • TABLE 163 ROAPAC: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 164 ROAPAC: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 165 ROAPAC: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 166 ROAPAC: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 167 ROAPAC: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 168 ROAPAC: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 10.5 REST OF THE WORLD
    • TABLE 169 ROW: DIGITAL PATHOLOGY MARKET, BY REGION, 2018-2025 (USD MILLION)
    • TABLE 170 ROW: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 171 ROW: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 172 ROW: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 173 ROW: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 174 ROW: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 175 ROW: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • TABLE 176 ROW: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2018-2025 (USD MILLION)
    • TABLE 177 ROW: DIGITAL PATHOLOGY SCANNERS MARKET, BY END USER, 2018-2025 (UNITS)
    • 10.5.1 LATIN AMERICA
      • 10.5.1.1 Increasing purchasing power and healthcare affordability to drive the market growth in Latin America
    • TABLE 178 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 179 LATIN AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 180 LATIN AMERICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 181 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 182 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 183 LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
    • 10.5.2 MIDDLE EAST & AFRICA
      • 10.5.2.1 Infrastructural developments in the region to support market growth
    • TABLE 184 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
    • TABLE 185 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 186 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 187 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
    • TABLE 188 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
    • TABLE 189 MIDDLE EAST & AFRICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 INTRODUCTION
  • 11.2 MARKET EVALUATION FRAMEWORK
    • FIGURE 32 MARKET EVALUATION FRAMEWORK: PARTNERSHIPS AND COLLABORATIONS WERE THE MOST WIDELY ADOPTED STRATEGIES
  • 11.3 MARKET SHARE ANALYSIS
    • FIGURE 33 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019
  • 11.4 DIGITAL PATHOLOGY MARKET: GEOGRAPHICAL ASSESSMENT
    • FIGURE 34 GEOGRAPHIC ASSESSMENT OF KEY PLAYERS IN THE DIGITAL PATHOLOGY MARKET (2019)
  • 11.5 DIGITAL PATHOLOGY MARKET: R&D EXPENDITURE
    • FIGURE 35 R&D EXPENDITURE OF KEY PLAYERS IN THE DIGITAL PATHOLOGY MARKET (2019)
  • 11.6 COMPETITIVE SCENARIO
    • 11.6.1 KEY DEVELOPMENTS IN THE DIGITAL PATHOLOGY MARKET
    • TABLE 190 PARTNERSHIPS & COLLABORATIONS (JANUARY 2017-SEPTEMBER 2020)
    • 11.6.2 KEY PRODUCT LAUNCHES
    • TABLE 191 PRODUCT LAUNCHES (JANUARY 2017-SEPTEMBER 2020)
    • 11.6.3 KEY EXPANSIONS
    • TABLE 192 EXPANSIONS (JANUARY 2017-SEPTEMBER 2020)

12 COMPANY EVALUATION MATRIX & COMPANY PROFILES

  • 12.1 COMPANY EVALUATION MATRIX DEFINITION & METHODOLOGY
  • 12.2 COMPANY EVALUATION MATRIX
    • 12.2.1 STARS
    • 12.2.2 EMERGING LEADERS
    • 12.2.3 PERVASIVE
    • 12.2.4 PARTICIPANTS
    • FIGURE 36 DIGITAL PATHOLOGY MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019
  • 12.3 COMPETITIVE LEADERSHIP MAPPING: STARTUPS/SMES
    • 12.3.1 PROGRESSIVE COMPANIES
    • 12.3.2 STARTING BLOCKS
    • 12.3.3 RESPONSIVE COMPANIES
    • 12.3.4 DYNAMIC COMPANIES
    • FIGURE 37 COMPETITIVE LEADERSHIP MAPPING OF THE DIGITAL PATHOLOGY MARKET: STARTUPS/SMES
  • 12.4 COMPANY PROFILES

(Business overview, Products offered, Recent developments & MnM View)**

    • 12.4.1 LEICA BIOSYSTEMS
    • FIGURE 38 DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
    • 12.4.2 KONINKLIJKE PHILIPS
    • FIGURE 39 KONINKLIJKE PHILIPS: COMPANY SNAPSHOT (2019)
    • 12.4.3 HAMAMATSU PHOTONICS
    • FIGURE 40 HAMAMATSU PHOTONICS: COMPANY SNAPSHOT (2019)
    • 12.4.4 F. HOFFMANN-LA ROCHE LTD.
    • FIGURE 41 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2019)
    • 12.4.5 SECTRA AB
    • FIGURE 42 SECTRA AB: COMPANY SNAPSHOT (2019)
    • 12.4.6 3DHISTECH
    • 12.4.7 APOLLO ENTERPRISE IMAGING CORP.
    • 12.4.8 XIFIN, INC.
    • 12.4.9 HURON DIGITAL PATHOLOGY
    • 12.4.10 VISIOPHARM
    • 12.4.11 CORISTA
    • 12.4.12 INDICA LABS
    • 12.4.13 OBJECTIVE PATHOLOGY SERVICES
    • 12.4.14 OPTRASCAN, INC.
    • 12.4.15 GLENCOE SOFTWARE, INC.
    • 12.4.16 PAIGE

*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.

  • 12.5 OTHER COMPANIES
    • 12.5.1 PATHAI
    • 12.5.2 KONFOONG BIOTECH INTERNATIONAL CO., LTD.
    • 12.5.3 INSPIRATA, INC.
    • 12.5.4 MIKROSCAN TECHNOLOGIES, INC.
    • 12.5.5 PROSCIA, INC.
    • 12.5.6 KANTERON SYSTEMS

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.